![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Financial & competing interests disclosure
The author declares receiving funding from EU FP7 Framework programme (IMMODGEL grant no. 602694) for development of immunomodulatory systems to control adverse immune reactions. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Additional information
Funding
The author declares receiving funding from EU FP7 Framework programme (IMMODGEL grant no. 602694) for development of immunomodulatory systems to control adverse immune reactions. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.